Physician profile
Joseph Nolan
NPI 1679576813
$3,782.12
in general payments reported to CMS, 2019-2025
38 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $710 · 2020: $556 · 2021: $532 · 2022: $1,128 · 2023: $408 · 2024: $249 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $857.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $706.14 | 2022-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Collegium Pharmaceutical, INC. | $251.51 | 2019-2024 | Xtampza, Belbuca |
| Abbvie INC. | $243.74 | 2022-2024 | |
| Vertos Medical, INC. | $175.94 | 2021-2024 | Mild Device Kit |
| Pfizer INC. | $173.81 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $170.56 | 2019-2022 | |
| Mml US, INC. | $165.34 | 2022 | |
| Tersera Therapeutics LLC | $164.91 | 2020-2022 | |
| Medtronic USA, INC. | $153.17 | 2019-2020 | |
| Flowonix Medical Incorporated | $142.01 | 2019 | |
| Grt US Holding, INC. | $138.29 | 2022 | |
| Forte Bio-Pharma LLC | $121.27 | 2020-2021 | |
| Ibsa Pharma INC. | $118.87 | 2021-2023 | Tirosint, Licart |
| Electronic Waveform Lab, INC. | $96.14 | 2020-2023 | |
| Boston Scientific Corporation | $89.48 | 2024 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Virtus Pharmaceuticals LLC | $81.86 | 2021 | |
| Arbor Pharmaceuticals, INC. | $78.20 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $75.90 | 2021 | |
| Protega Pharmaceutials INC | $65.25 | 2022-2023 | Roxybond |
| Smith+Nephew, INC. | $63.15 | 2022-2024 | Grafix Pl |
| Redhill Biopharma INC. | $58.95 | 2021 | |
| Painteq LLC | $54.08 | 2023 | Painteq |
| Pacira Therapeutics, INC. | $53.42 | 2019 | |
| Sentynl Therapeutics, INC. | $46.51 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $42.26 | 2019 | |
| Nevro Corp. | $38.63 | 2019-2023 | Senza |
| Zyla Life Sciences, INC. | $36.54 | 2019 | |
| Eisai INC. | $29.54 | 2020-2021 | |
| Bioventus LLC | $22.02 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.36 | 2021 | |
| Amgen INC. | $16.79 | 2020 | |
| Alnylam Pharmaceuticals INC. | $13.93 | 2021 | |
| Novo Nordisk INC | $13.35 | 2019 | |
| Abbott Laboratories | $12.81 | 2022 | |
| Si-Bone, INC. | $12.44 | 2020 | |
| Almatica Pharma LLC | $12.00 | 2021 | |
| Cashflow Solutions, LLC | $11.78 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Mdd US Operations, LLC | $11.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Nolan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.